Management of Guillain-Barré syndrome.
Guillain-Barré syndrome is a predominantly motor polyradiculoneuropathy in which neurological deficit reaches a peak within 1 month of onset. Seventy per cent of patients recover within 1 year, but 10% die and 20% have residual disability. Plasma exchange is advocated for severe cases early in the course of the disease but the role of steroids has yet to be determined.
Ferner
R
R
United Medical School, Guy's Hospital, London.
Barnett
M
M
Hughes
R A
RA
D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010951:Plasma Exchange / Q000379:methods; D011129:Polyradiculoneuropathy / Q000150:complications / Q000401:mortality / Q000628:therapy*
D005938:Glucocorticoids